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mitofusin-2 expression, consequent mito-
chondrial fragmentation, andmultiple bio-
energetic defects that likely decrease
insulin effectiveness (Bach et al., 2003).
Proapoptotic BAX binds to mitochondrial
fission sites, interacts there with mito-
chondrial fission proteins, and may play
a role in apoptotic mitochondrial fragmen-
tation. BAX or BAK is required for mito-
chondrial fusion in normal fibroblasts and
kidney cell lines (Karbowski et al., 2006).
Early dysregulation of the BAD-GK com-
plex due to phosphorylation or decreased
mitochondrial binding could cause de-
creased insulin secretion, perhaps in
part mediated by reactive oxygen species
(ROS) production in the mitochondria
leading to further BAX release, stimulating
mitochondrial fission in diabetic islets.
T2DM is thought to arise from a lack of
functional b cell mass in the face of insulin
resistance. Overwork of b cells in a failed
attempt to compensate for increased in-
sulin demand could contribute to a defect
in the BAD-GK-mitochondrion interac-
tion, setting off a cascade of events lead-
ing to further insulin resistance and hyper-
glycemia (Fridlyand and Philipson, 2004;
Muoio and Newgard, 2008). Although in-
creased GSIS might temporarily improve
the diabetic state, oxidative stress conse-
quent to overproduction of ROS by both
oxidative phosphorylation in mitochon-
dria and elevated proinsulin translation in
the endoplasmic reticulum may eventu-
ally lead to b cell failure (Fridlyand and
Philipson, 2004). Integrating causes of
both insulin resistance and b cell failure
due to metabolic stress factors would
lead to a unifying mechanistic hypothesis
for T2DM (Muoio and Newgard, 2008).
Treatment interventions targeting muscle
mitochondrial function or number could
improve insulin resistance pathways,
which would reduce the demand for insu-
lin. Simultaneously, functional inhibition of
b cells along with incretin agonist therapy
might allow recovery from metabolic
stress. Together, these approaches in ef-
fect could replicate the impressive results
in ameliorating or preventing T2DM
achieved by intensive exercise and signif-
icant weight loss. By establishing BAD
as an important metabolic and survival
sensor in b cells, Danial and colleagues
(2008) have provided exciting new infor-
mation necessary for improving our un-
derstanding of b cell biology and possible
mechanisms underlying the pathophysiol-
ogy of the growing epidemic of diabetes.
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In Drosophila, a simple network of nutrient-sensing neuroendocrine cells, analogs of pancreatic islet a and
b cells, regulates carbohydrate metabolism. Work presented in this issue of Cell Metabolism (Buch et al.,
2008) shows that signals from these cells control expression of a glycogen-specific glucosidase in response
to dietary protein and carbohydrate.The modern, postgenome era is seeing
a resurgence of insect physiology, focus-
ing on Drosophila as a model system. A
key question to address is, how do nutri-
tion and endocrine circuits affect gene
expression? This question is of particularinterest because dietary status in animals
controls life span, metabolic disease,
and growth. Recent studies in flies have
usedmicroarray analysis to identify genes
whose levels of expression change in re-
sponse to starvation or dietary intake ofCell Metasugar (Zinke et al., 2002) or protein (Gersh-
man et al., 2007). These studies have iden-
tified genes encoding components of
known carbohydrate and lipid metabolic
pathways and macromolecular synthesis
pathways, aswell asmanyuncharacterizedbolism 7, April 2008 ª2008 Elsevier Inc. 281
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Previewsgenes. A further question
these studies raise is, what
endocrine and biochemical
pathways regulate these
changes in gene expression
in response to dietary compo-
sition? New work in this issue
from Buch et al. (2008) dem-
onstrates that glycogen stor-
age, glycogen utilization, and
perhaps carbohydrate uptake
are regulated not simply by
well-defined physiological
pathways but by coordinated
neuroendocrine control of tar-
get gene expression.
Buch et al. (2008) show that
an evolutionarily conserved
a-glucosidase is a highly reg-
ulated target of insulin signal-
ing in Drosophila. a-glucosi-
dase is a g-amylase with
specificity for glycogen and
other oligoglucosides that is
highly conserved across ani-
mal phylogeny. This new
study finds that in Drosophila,
expression of the a-glucosi-
dase gene target of brain insulin (tobi) is
controlled through interaction of two neu-
roendocrine cell types, the brain insulin-
producing cells (IPCs) and the glucagon-
like hormone-producing corpora cardiaca
(CC) cells. This IPC-CC axis has been pre-
viously compared to the b and a cell net-
work of the mammalian pancreatic islet,
as well as to the hypothalamic-pituitary
axis (Rulifson et al., 2002; Wang et al.,
2007). Apparently, this functional and an-
atomic neuroendocrine circuit can sense
the ratio of protein to carbohydrate in
the diet and thereby regulate target genes
to coordinate nutrient status with energy
metabolism and protein synthesis.
tobiwas identified in microarray studies
of gene expression in adult flies with
ablated IPCs as being highly regulated
(17-fold) by brain IPC insulin. tobi is ex-
pressed in the adult anterior midgut (the
fly’s anterior small intestine) and in the fat-
and glycogen-storing fat body. Ectopic
transgene expression confirmed that tobi
activity reduces glycogen stores, sup-
porting the function as predicted from its
sequence homology to a-glucosidases.
Moreover, knockdown of tobi expression
leads to a significant increase in glycogen
and a concomitant drop in blood sugar
concentration.
tobi gene expression is dynamic and re-
sponds to dietary composition. It is high
on a diet of protein-rich yeast paste but
low on relatively sugar-rich standard fly
food and varies similarly over a range of
dietary protein/sugar ratios. Levels of tobi
expression seem to be set through in-
dependent positive regulation by dietary
protein and repressive regulation by die-
tary sugar. Thus, the highest tobi expres-
sion correlates with high insulin signaling
activity and occurs on a high protein/
low sugar diet; lowest expression of tobi
occurs on a high sugar/low protein diet
and correlates with lower insulin signaling
activity (see Figure 1 for summary). How-
ever, any response of tobi expression
to dietary intake depends entirely on
IPC function and, presumably, insulin
release.
The differential response of tobi expres-
sion to protein and sugar levels is analo-
gous to glucagon secretion by islet a cells,
which are stimulated to secrete glucagon
by either high amino acid levels or low glu-
cose levels (Unger and Orci, 1994). In this
vein, tobi expression depends entirely on
the activity of the CC cells, which analo-
gously to a cells maintain normoglycemia
through secretion of a glucagon-like hor-
mone, adipokinetic hormone (AKH). Thus,
both IPCs and CC cells are
essential for the response of
tobi to diet.
Is the IPC-CC circuit serial,
or do these cell types provide
parallel inputs to the tobi
gene? Buch and colleagues
(2008) found that IPCs and
CC cells mutually antagonize
each other’s hormone ex-
pression levels: ablation of
IPCs elevates akh gene ex-
pression, and ablation of CC
cells elevates insulin gene ex-
pression in IPCs. This mutual
antagonism cannot, how-
ever, explain the observation
that both cell types are re-
quired for tobi activation.
Thus, it is reasonable to con-
jecture that the circuit must
provide parallel inputs to the
tobi gene. However, the de-
tails of individual nutrient
sensing and signaling contri-
butions by the IPCs and CC
cells remain unresolved.
What is the contribution of
canonical insulin signaling to tobi regula-
tion? dFOXO, a transcription factor that
is inhibited by insulin signaling, is required
for a fraction of tobi expression, suggest-
ing an activator role for dFOXO. However,
dFOXO activity levels are lowest when
tobi levels are highest, and vice versa,
suggesting a repressor role for dFOXO.
The exact role of dFOXO is therefore not
clear from this study, but the existence
of an additional pathway can reasonably
be inferred. It is proposed that this alter-
native pathway might be a target of CC
cell signaling.
It is interesting to consider that these
regulatory relationships within the IPC-CC
axis are not entirely new insights; they
had already been demonstrated to some
extent in now classic insect physiology
studies. For example, fat body glycogen
level was shown to be negatively regulated
by the IPCs in a blowfly model (Thomsen,
1952), and CC cells were shown to secrete
AKH to regulate glycogen hydrolysis via
cAMP-mediated activation of glycogen
phosphorylase in a cockroach model
(Steele, 1961; Hanaoka and Takahashi,
1977). These and subsequent studies
drew parallels to the biology of insulin and
glucagon inmammals, providing a glimpse
of evolutionary conservation in the biology
Figure 1. tobi and Nutrient Sensing in Drosophila
A nutrient-sensing pancreatic islet-like neuroendocrine circuit controls glyco-
gen breakdown through coordinated regulation of the a-glucosidase gene tobi
(Buch et al., 2008). The brain insulin-producing cells (IPCs and insulin, red) and
the glucagon-like hormone-producing corpora cardiaca cells (CC and AKH,
green) are both essential for endocrine regulation of tobi expression in the
gut and fat body (pale yellow oval). The level of tobi gene expression can
switch between two extreme dietary conditions (bold up/down arrows). tobi
gene expression is maximal on a high protein/low sugar diet (upper diagram)
and is accompanied by elevated insulin signaling (filled red cell and more
secreted dots), reduced akh transcription (empty green cell), and increased
glycogenolysis and overall protein synthesis. tobi gene expression is minimal
on a high sugar/low protein diet (lower diagram) and is accompanied by re-
duced insulin signaling (empty red cell and fewer secreted dots), elevated
akh transcription (filled green cell), and decreased glycogenolysis and overall
protein synthesis. Secretion of AKH and its activity were not determined in
the study.282 Cell Metabolism 7, April 2008 ª2008 Elsevier Inc.
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Previewsof metabolism. What is novel and exciting
in the work of Buch et al. (2008) is the com-
bination of gene regulation studies, endo-
crinology, and physiology in a model ge-
netic organism whose genome and gene
regulatory linkages can be readily com-
pared to the human genome.
The significance of these results for
human biology is indeed compelling. Mu-
tations in the acid a-glucosidase gene
(GAA) are the basis for Pompe disease,
or glycogen storage disease II, in which
a lack of a-glucosidase activity in lyso-
somes results in destructive glycogen ac-
cumulation (Hirschhorn, 1995). Though
now treatable with enzyme replacement,
unmanaged the disease pathology can
present devastating cardiac and skeletal
muscle weakness, and, in its infantile-on-
set forms, heart failure may result. On the
other hand, a-glucosidase inhibitors are a
widely used oral medication for type 2 dia-
betes mellitus (van de Laar et al., 2005).
These inhibitors acton intestinala-glucosi-
dase to block the hydrolysis of complex
carbohydrates, resulting in slowed uptake
of glucose and other monosaccharides
and decreased postprandial demands for
pancreatic b cell insulin secretion.Bruton and Tec: N
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Enhanced and deficient immune res
Shinohara et al. (2008) shows that p
munity and bone as well as two sign
A strong, healthy skeleton enables mobil-
ity and is especially important for the
growing number of aging individuals who
will live long enough to develop osteopo-
rosis. Fewpeople are aware that the yearly
incidence of osteoporotic fractures in
women is greater than that of heart
attacks, strokes, and breast cancer com-
bined. What’s more, osteoporosis can
complicate autoimmune diseases such
as rheumatoid arthritis, in which immuneRemarkably, this strategy of unburden-
ing insulin-producing b cells from high
levels of sustained insulin secretion may
already be wired into the neuroendocrine
control of dietary carbohydrate uptake
in Drosophila. Indeed, the expression of
tobi in the gut would support such a role,
linking high-carbohydrate diet to reduced
uptake of sugar, though this has not yet
been tested. It is most likely that fat body
expression of tobi facilitates release of
glucose stores when insulin signaling,
CC cell activity, and protein synthesis are
elevated. This characteristic corelease of
insulin and glucagon in response to amino
acids is also anobserved feature of human
islet biology (Unger andOrci, 1994). Given
the accumulating parallels between the
islet-like cells of Drosophila and the pan-
creatic islets of mammals, it would not
be surprising if this homeostatic mecha-
nism, and possibly others yet to
be found, is evolutionarily conserved be-
tween flies and humans.
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bone homeostasis. A new study by
e kinases Bruton and Tec links im-
clasts, the cells that degrade bone.
trenches are dug on the surfaces of the
spongy bone in marrow cavities by osteo-
clasts and then filled with new bone
by bone-building osteoblasts. Osteopo-
rosis occurs when the amount of bone
removed by osteoclasts exceeds that
laid down by osteoblasts. Conversely, os-
teopetrosis occurs during embryonic de-
velopment when osteoclast formation or
function is defective and bones become
denser (Karsenty and Wagner, 2002).
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